STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

MBIO MUSTANG BIO INCORPORATED StockScouter® Report

4

StockScouter® Score

MUSTANG BIO INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
  • The multi-period measure of relative price change and consistency is average. Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

D
C
A
C

Previous Ratings

3
4
3